How will we know whether HD-lowering treatments are working? New advancements in the detection of mutant huntingtin.
Day 2 of updates from the annual HD Therapeutics Conference in Palm Springs
A new study shows a synthetic oil called triheptanoin changes how HD brains use energy. But will it help HD?
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?
Can drug trials that fail be helpful? A HD mouse study provides solid evidence of an approach that doesn't help HD
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease